Genmab | GEN - Ordinary Share Capital


Genmab reported DKK61.62M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Agios Pharmaceuticals USD 59.34M 892K Mar/2026
Almirall EUR 214.79M 0 Dec/2025
Amarin USD 20.81M 13K Dec/2025
Amgen USD 540M 1000K Mar/2026
AstraZeneca USD 1.55B 73K Mar/2026
Bayer EUR 982.42M 0 Dec/2025
BioMarin Pharmaceutical USD 193.27M 969K Mar/2026
Demant DKK 210.9M 5.18M Dec/2025
Exelixis USD 253.7M 8.78M Mar/2026
Fresenius Medical Care EUR 270.09M 9.2M Mar/2026
Genmab DKK 61.62M 52K Dec/2025
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
GN Store Nord DKK 145.61M 0 Mar/2026
GRIFOLS EUR 680.58M 0 Mar/2026
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Insmed USD 216.52M 2.27M Mar/2026
Lakefront Biotherapeutics EUR 65.9M 0 Mar/2026
Lonza CHF 68.64M 0 Dec/2025
Merck EUR 434.78M 0 Mar/2026
Novartis USD 1.91B 60K Mar/2026
Regeneron Pharmaceuticals USD 105M 300K Mar/2026
Roche Holding CHF 795.62M 699.54K Dec/2025
Sanofi EUR 1.21B 8.25M Mar/2026
UCB EUR 190.36M 365.15K Dec/2025